BETWEEN:
1. | ALBA BIOSCIENCE LIMITED (company number SC310584) whose registered office is at Allan-Robb Campus, 5 James Hamilton Way, Milton Bridge, Penicuik, EH26 0BF(“the Company”) and |
2. | Ernest Larnach of 21 Bonaly Gardens, Edinburgh, EH13 0EX (“the Executive”) |
IT IS AGREED as follows:
1. | DEFINITIONS AND INTERPRETATION |
1.1 | In this Agreement, unless the context otherwise requires, the following expressions have the following meanings: |
“Agreement”means this Agreement (including any schedule or annexure to it and any document referred to in it or in agreed form);
“Board”meansthe board of directors of the Company from time to time and includes any committee of the Board duly appointed by it;
“Business”meansthe manufacture and sale of blood-typing reagents and associated technologies and any trade or other commercial activity which is carried on by the Company, or which the Company shall have determined to carry on with a view to profit in the immediate or foreseeable future;
“Capacity”means as agent, consultant, director, employee, owner, partner, shareholder or in any other capacity;
“Confidential Information” any trade secrets or other information which is confidential, commercially sensitive and is not in the public domain relating or belonging to the Company or any Group Company including but not limited to information relating to the business methods, corporate plans, management systems, finances, new business opportunities, research and development projects, marketing or sales of any past, present or future product or service, secret formulae, processes, inventions, designs,know-how discoveries, technical specifications and other technical information relating to the creation, production or supply of any past, present or future product or service of the Company or any Group Company, lists or details of clients, potential clients or suppliers or the arrangements made with any client or supplier of the Company or any Group Company and any information in respect of which the Company owes an obligation of confidentiality to any third party;
Page 3 of 23